GO:0045667 | regulation of osteoblast differentiation | 7.01e-05 | 6.84e-01 | 7.253 | 2 | 2 | 8 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.37e-04 | 1.00e+00 | 6.794 | 2 | 4 | 11 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 1 |
GO:0048742 | regulation of skeletal muscle fiber development | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 2 |
GO:0006684 | sphingomyelin metabolic process | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 2 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 2 |
GO:0009798 | axis specification | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 2 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 3 |
GO:0030375 | thyroid hormone receptor coactivator activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 3 |
GO:0004767 | sphingomyelin phosphodiesterase activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 3 |
GO:0019887 | protein kinase regulator activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 3 |
GO:0045292 | mRNA cis splicing, via spliceosome | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 2 | 4 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 5 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 5 |
GO:0031274 | positive regulation of pseudopodium assembly | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 5 |
GO:0008285 | negative regulation of cell proliferation | 9.61e-03 | 1.00e+00 | 2.725 | 3 | 11 | 277 |
GO:0030858 | positive regulation of epithelial cell differentiation | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 2 | 6 |
GO:0045670 | regulation of osteoclast differentiation | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 7 |
GO:0030877 | beta-catenin destruction complex | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 7 |
GO:2000273 | positive regulation of receptor activity | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 8 |
GO:0031116 | positive regulation of microtubule polymerization | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 8 |
GO:0005845 | mRNA cap binding complex | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 8 |
GO:0031122 | cytoplasmic microtubule organization | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 4 | 8 |
GO:0010390 | histone monoubiquitination | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 2 | 8 |
GO:0045295 | gamma-catenin binding | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 9 |
GO:0010225 | response to UV-C | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 9 |
GO:0019789 | SUMO ligase activity | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 9 |
GO:0032886 | regulation of microtubule-based process | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 9 |
GO:0044295 | axonal growth cone | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 9 |
GO:0006379 | mRNA cleavage | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 9 |
GO:0005634 | nucleus | 1.55e-02 | 1.00e+00 | 0.911 | 10 | 158 | 3246 |
GO:0005095 | GTPase inhibitor activity | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 10 |
GO:0006974 | cellular response to DNA damage stimulus | 1.63e-02 | 1.00e+00 | 3.335 | 2 | 11 | 121 |
GO:0043409 | negative regulation of MAPK cascade | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 10 |
GO:0051010 | microtubule plus-end binding | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 2 | 11 |
GO:0007026 | negative regulation of microtubule depolymerization | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 2 | 11 |
GO:0046716 | muscle cell cellular homeostasis | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 11 |
GO:0008334 | histone mRNA metabolic process | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 11 |
GO:0051276 | chromosome organization | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 2 | 12 |
GO:0004527 | exonuclease activity | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 4 | 12 |
GO:0035371 | microtubule plus-end | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 2 | 13 |
GO:0010906 | regulation of glucose metabolic process | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 1 | 13 |
GO:0008156 | negative regulation of DNA replication | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 1 | 13 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 3 | 14 |
GO:0016575 | histone deacetylation | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 2 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 4 | 15 |
GO:0016922 | ligand-dependent nuclear receptor binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 15 |
GO:0000281 | mitotic cytokinesis | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 3 | 15 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 1 | 16 |
GO:0003887 | DNA-directed DNA polymerase activity | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 2 | 16 |
GO:0009954 | proximal/distal pattern formation | 2.75e-02 | 1.00e+00 | 5.166 | 1 | 2 | 17 |
GO:0009953 | dorsal/ventral pattern formation | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 18 |
GO:0031047 | gene silencing by RNA | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 18 |
GO:0035257 | nuclear hormone receptor binding | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 18 |
GO:0016573 | histone acetylation | 3.07e-02 | 1.00e+00 | 5.005 | 1 | 1 | 19 |
GO:0006913 | nucleocytoplasmic transport | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 2 | 20 |
GO:0045296 | cadherin binding | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 1 | 20 |
GO:0001942 | hair follicle development | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 21 |
GO:0004842 | ubiquitin-protein transferase activity | 3.39e-02 | 1.00e+00 | 2.770 | 2 | 17 | 179 |
GO:0016925 | protein sumoylation | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 3 | 22 |
GO:0051781 | positive regulation of cell division | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 1 | 22 |
GO:0006687 | glycosphingolipid metabolic process | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 1 | 22 |
GO:0003713 | transcription coactivator activity | 3.56e-02 | 1.00e+00 | 2.730 | 2 | 21 | 184 |
GO:0005881 | cytoplasmic microtubule | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 3 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 6 | 24 |
GO:0005902 | microvillus | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 1 | 25 |
GO:0048538 | thymus development | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 1 | 25 |
GO:0005913 | cell-cell adherens junction | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 3 | 25 |
GO:0007094 | mitotic spindle assembly checkpoint | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 4 | 25 |
GO:0009267 | cellular response to starvation | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 1 | 26 |
GO:0033077 | T cell differentiation in thymus | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 2 | 26 |
GO:0045785 | positive regulation of cell adhesion | 4.65e-02 | 1.00e+00 | 4.395 | 1 | 3 | 29 |
GO:0070830 | tight junction assembly | 4.65e-02 | 1.00e+00 | 4.395 | 1 | 1 | 29 |
GO:0006446 | regulation of translational initiation | 4.65e-02 | 1.00e+00 | 4.395 | 1 | 2 | 29 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 3 | 30 |
GO:0004402 | histone acetyltransferase activity | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 3 | 30 |
GO:0050681 | androgen receptor binding | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 30 |
GO:0005654 | nucleoplasm | 4.89e-02 | 1.00e+00 | 1.479 | 4 | 68 | 876 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 4.96e-02 | 1.00e+00 | 4.299 | 1 | 6 | 31 |
GO:0016328 | lateral plasma membrane | 4.96e-02 | 1.00e+00 | 4.299 | 1 | 2 | 31 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 4.96e-02 | 1.00e+00 | 4.299 | 1 | 1 | 31 |
GO:0035019 | somatic stem cell maintenance | 5.12e-02 | 1.00e+00 | 4.253 | 1 | 3 | 32 |
GO:0007254 | JNK cascade | 5.43e-02 | 1.00e+00 | 4.166 | 1 | 1 | 34 |
GO:0060041 | retina development in camera-type eye | 5.43e-02 | 1.00e+00 | 4.166 | 1 | 1 | 34 |
GO:0045732 | positive regulation of protein catabolic process | 5.43e-02 | 1.00e+00 | 4.166 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 5 | 35 |
GO:0030521 | androgen receptor signaling pathway | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 3 | 35 |
GO:0031124 | mRNA 3'-end processing | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 4 | 35 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 5.90e-02 | 1.00e+00 | 4.044 | 1 | 2 | 37 |
GO:0003743 | translation initiation factor activity | 5.90e-02 | 1.00e+00 | 4.044 | 1 | 8 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 4 | 38 |
GO:0006665 | sphingolipid metabolic process | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 1 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 5 | 38 |
GO:0003723 | RNA binding | 6.06e-02 | 1.00e+00 | 2.305 | 2 | 22 | 247 |
GO:0003684 | damaged DNA binding | 6.52e-02 | 1.00e+00 | 3.896 | 1 | 1 | 41 |
GO:0006406 | mRNA export from nucleus | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 7 | 44 |
GO:0007409 | axonogenesis | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 2 | 45 |
GO:0008013 | beta-catenin binding | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 3 | 45 |
GO:0032587 | ruffle membrane | 7.89e-02 | 1.00e+00 | 3.610 | 1 | 3 | 50 |
GO:0060070 | canonical Wnt signaling pathway | 8.04e-02 | 1.00e+00 | 3.581 | 1 | 1 | 51 |
GO:0001822 | kidney development | 8.19e-02 | 1.00e+00 | 3.553 | 1 | 3 | 52 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 8.19e-02 | 1.00e+00 | 3.553 | 1 | 8 | 52 |
GO:0006302 | double-strand break repair | 8.19e-02 | 1.00e+00 | 3.553 | 1 | 5 | 52 |
GO:0042393 | histone binding | 8.50e-02 | 1.00e+00 | 3.499 | 1 | 3 | 54 |
GO:0000776 | kinetochore | 8.65e-02 | 1.00e+00 | 3.472 | 1 | 8 | 55 |
GO:0008584 | male gonad development | 8.95e-02 | 1.00e+00 | 3.421 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 9.10e-02 | 1.00e+00 | 3.395 | 1 | 5 | 58 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 9.25e-02 | 1.00e+00 | 3.371 | 1 | 5 | 59 |
GO:0009952 | anterior/posterior pattern specification | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 3 | 60 |
GO:0006464 | cellular protein modification process | 9.55e-02 | 1.00e+00 | 3.323 | 1 | 4 | 61 |
GO:0030018 | Z disc | 9.99e-02 | 1.00e+00 | 3.253 | 1 | 3 | 64 |
GO:0005923 | tight junction | 9.99e-02 | 1.00e+00 | 3.253 | 1 | 2 | 64 |
GO:0003676 | nucleic acid binding | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 4 | 66 |
GO:0006355 | regulation of transcription, DNA-templated | 1.07e-01 | 1.00e+00 | 1.357 | 3 | 31 | 715 |
GO:0030308 | negative regulation of cell growth | 1.09e-01 | 1.00e+00 | 3.124 | 1 | 3 | 70 |
GO:0001649 | osteoblast differentiation | 1.15e-01 | 1.00e+00 | 3.044 | 1 | 5 | 74 |
GO:0016605 | PML body | 1.22e-01 | 1.00e+00 | 2.950 | 1 | 5 | 79 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.25e-01 | 1.00e+00 | 1.695 | 2 | 21 | 377 |
GO:0030529 | ribonucleoprotein complex | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 5 | 82 |
GO:0005730 | nucleolus | 1.29e-01 | 1.00e+00 | 1.004 | 4 | 74 | 1217 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.29e-01 | 1.00e+00 | 2.861 | 1 | 5 | 84 |
GO:0030027 | lamellipodium | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 3 | 88 |
GO:0044255 | cellular lipid metabolic process | 1.36e-01 | 1.00e+00 | 2.778 | 1 | 2 | 89 |
GO:0006461 | protein complex assembly | 1.39e-01 | 1.00e+00 | 2.746 | 1 | 2 | 91 |
GO:0000209 | protein polyubiquitination | 1.41e-01 | 1.00e+00 | 2.730 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.41e-01 | 1.00e+00 | 2.730 | 1 | 6 | 92 |
GO:0007050 | cell cycle arrest | 1.41e-01 | 1.00e+00 | 2.730 | 1 | 4 | 92 |
GO:0006260 | DNA replication | 1.43e-01 | 1.00e+00 | 2.699 | 1 | 9 | 94 |
GO:0046983 | protein dimerization activity | 1.43e-01 | 1.00e+00 | 2.699 | 1 | 2 | 94 |
GO:0016477 | cell migration | 1.46e-01 | 1.00e+00 | 2.668 | 1 | 3 | 96 |
GO:0008017 | microtubule binding | 1.48e-01 | 1.00e+00 | 2.653 | 1 | 9 | 97 |
GO:0006413 | translational initiation | 1.51e-01 | 1.00e+00 | 2.624 | 1 | 6 | 99 |
GO:0030335 | positive regulation of cell migration | 1.53e-01 | 1.00e+00 | 2.595 | 1 | 2 | 101 |
GO:0042981 | regulation of apoptotic process | 1.69e-01 | 1.00e+00 | 2.446 | 1 | 4 | 112 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.70e-01 | 1.00e+00 | 1.421 | 2 | 29 | 456 |
GO:0007049 | cell cycle | 1.73e-01 | 1.00e+00 | 2.408 | 1 | 8 | 115 |
GO:0016607 | nuclear speck | 1.82e-01 | 1.00e+00 | 2.323 | 1 | 8 | 122 |
GO:0005515 | protein binding | 1.88e-01 | 1.00e+00 | 0.414 | 9 | 198 | 4124 |
GO:0000398 | mRNA splicing, via spliceosome | 1.90e-01 | 1.00e+00 | 2.253 | 1 | 15 | 128 |
GO:0031625 | ubiquitin protein ligase binding | 2.04e-01 | 1.00e+00 | 2.145 | 1 | 7 | 138 |
GO:0044212 | transcription regulatory region DNA binding | 2.10e-01 | 1.00e+00 | 2.094 | 1 | 13 | 143 |
GO:0016874 | ligase activity | 2.14e-01 | 1.00e+00 | 2.064 | 1 | 11 | 146 |
GO:0004871 | signal transducer activity | 2.17e-01 | 1.00e+00 | 2.044 | 1 | 4 | 148 |
GO:0010467 | gene expression | 2.18e-01 | 1.00e+00 | 1.190 | 2 | 49 | 535 |
GO:0001701 | in utero embryonic development | 2.25e-01 | 1.00e+00 | 1.987 | 1 | 7 | 154 |
GO:0008380 | RNA splicing | 2.39e-01 | 1.00e+00 | 1.887 | 1 | 21 | 165 |
GO:0005737 | cytoplasm | 2.45e-01 | 1.00e+00 | 0.476 | 6 | 127 | 2633 |
GO:0016071 | mRNA metabolic process | 2.45e-01 | 1.00e+00 | 1.844 | 1 | 10 | 170 |
GO:0006412 | translation | 2.55e-01 | 1.00e+00 | 1.778 | 1 | 12 | 178 |
GO:0006351 | transcription, DNA-templated | 2.55e-01 | 1.00e+00 | 0.767 | 3 | 47 | 1076 |
GO:0016567 | protein ubiquitination | 2.67e-01 | 1.00e+00 | 1.699 | 1 | 14 | 188 |
GO:0016070 | RNA metabolic process | 2.67e-01 | 1.00e+00 | 1.699 | 1 | 10 | 188 |
GO:0007165 | signal transduction | 2.69e-01 | 1.00e+00 | 0.982 | 2 | 24 | 618 |
GO:0005743 | mitochondrial inner membrane | 2.78e-01 | 1.00e+00 | 1.631 | 1 | 9 | 197 |
GO:0043065 | positive regulation of apoptotic process | 2.84e-01 | 1.00e+00 | 1.595 | 1 | 7 | 202 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.85e-01 | 1.00e+00 | 0.922 | 2 | 29 | 644 |
GO:0006281 | DNA repair | 2.86e-01 | 1.00e+00 | 1.588 | 1 | 24 | 203 |
GO:0008134 | transcription factor binding | 2.93e-01 | 1.00e+00 | 1.546 | 1 | 10 | 209 |
GO:0005739 | mitochondrion | 2.94e-01 | 1.00e+00 | 0.889 | 2 | 32 | 659 |
GO:0019899 | enzyme binding | 2.94e-01 | 1.00e+00 | 1.539 | 1 | 7 | 210 |
GO:0005813 | centrosome | 3.02e-01 | 1.00e+00 | 1.492 | 1 | 10 | 217 |
GO:0019901 | protein kinase binding | 3.20e-01 | 1.00e+00 | 1.395 | 1 | 8 | 232 |
GO:0007155 | cell adhesion | 3.33e-01 | 1.00e+00 | 1.323 | 1 | 8 | 244 |
GO:0008270 | zinc ion binding | 3.37e-01 | 1.00e+00 | 0.748 | 2 | 39 | 727 |
GO:0003682 | chromatin binding | 3.42e-01 | 1.00e+00 | 1.276 | 1 | 15 | 252 |
GO:0043565 | sequence-specific DNA binding | 3.67e-01 | 1.00e+00 | 1.150 | 1 | 8 | 275 |
GO:0044822 | poly(A) RNA binding | 3.81e-01 | 1.00e+00 | 0.611 | 2 | 45 | 799 |
GO:0044281 | small molecule metabolic process | 4.08e-01 | 1.00e+00 | 0.532 | 2 | 35 | 844 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.10e-01 | 1.00e+00 | 0.945 | 1 | 17 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.34e-01 | 1.00e+00 | 0.840 | 1 | 23 | 341 |
GO:0044267 | cellular protein metabolic process | 4.44e-01 | 1.00e+00 | 0.794 | 1 | 14 | 352 |
GO:0046872 | metal ion binding | 4.61e-01 | 1.00e+00 | 0.386 | 2 | 24 | 934 |
GO:0006915 | apoptotic process | 4.98e-01 | 1.00e+00 | 0.570 | 1 | 15 | 411 |
GO:0005794 | Golgi apparatus | 5.01e-01 | 1.00e+00 | 0.556 | 1 | 6 | 415 |
GO:0016032 | viral process | 5.12e-01 | 1.00e+00 | 0.512 | 1 | 30 | 428 |
GO:0005886 | plasma membrane | 5.81e-01 | 1.00e+00 | 0.037 | 3 | 46 | 1784 |
GO:0005829 | cytosol | 5.82e-01 | 1.00e+00 | 0.035 | 3 | 88 | 1787 |
GO:0016020 | membrane | 6.06e-01 | 1.00e+00 | 0.016 | 2 | 56 | 1207 |
GO:0005887 | integral component of plasma membrane | 6.22e-01 | 1.00e+00 | 0.086 | 1 | 8 | 575 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.26e-01 | 1.00e+00 | 0.069 | 1 | 22 | 582 |
GO:0003677 | DNA binding | 8.05e-01 | 1.00e+00 | -0.634 | 1 | 52 | 947 |
GO:0016021 | integral component of membrane | 9.34e-01 | 1.00e+00 | -1.322 | 1 | 19 | 1526 |
GO:0070062 | extracellular vesicular exosome | 9.47e-01 | 1.00e+00 | -1.427 | 1 | 51 | 1641 |